RVL Pharmaceuticals plc

Pharmaceutical company · Bridgewater, New Jersey, United States

RVL Pharmaceuticals plc is a pharmaceutical company headquartered in Bridgewater, New Jersey, United States. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

RVL Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersBridgewater, New Jersey, United States
SEC industryPharmaceutical Preparations
SEC CIK1739426

What does RVL Pharmaceuticals do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5 million sold (2023).

Frequently asked questions about RVL Pharmaceuticals

Where is RVL Pharmaceuticals headquartered?

RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey, United States.

What does RVL Pharmaceuticals do?

RVL Pharmaceuticals plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences